Clinical Trials List
2012-08-31 - 2020-04-01
Phase III
Terminated5
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Po-Nan Wang Division of Hematology & Oncology
- Hung Chang Division of Hematology & Oncology
- Ming-Chung Kao Division of Hematology & Oncology
- 洪玉馨 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Li-Yuan Bai Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- HSIN-AN HOU Division of Hematology & Oncology
- Wen-Chien Chou Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- 林建廷 Division of Hematology & Oncology
- Shang-Ju Wu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
26 participants
-
Global
1718 participants
